论文部分内容阅读
目的:探讨药物治疗冠心病心绞痛的临床疗效,为此类疾病的临床治疗提供参考依据。方法:选取我院采用辛伐他汀联合低分子肝素钠治疗的心绞痛患者作为观察组,另选取采用一般抗心绞痛药物治疗的患者作为对照组。两组患者治疗2周后观察疗效及心电图变化。结果:用药疗效显示,观察组总有效率为94.5%,对照组总有效率为71.8%,两组相比,差异具有统计学意义(P<0.05);心电图变化显示,观察组总有效率为93.6%,对照组总有效率为75.5%。两组相比,差异具有统计学意义(P<0.05)。结论:使用药物治疗心血管内科心绞痛,疗效确切,安全性高,同时加用辛伐他汀联合低分子肝素钠,其疗效更为显著,值得推广使用。
Objective: To investigate the clinical efficacy of drug treatment of coronary heart disease angina pectoris, to provide reference for the clinical treatment of such diseases. Methods: The patients with angina pectoris treated with simvastatin and low molecular weight heparin sodium in our hospital were selected as the observation group, and the patients who were treated with general anti-anginal drugs were selected as the control group. Two groups of patients after treatment for 2 weeks to observe the efficacy and ECG changes. Results: The therapeutic effect showed that the total effective rate was 94.5% in the observation group and 71.8% in the control group, the difference was statistically significant (P <0.05); the changes of ECG showed that the total effective rate of the observation group was 93.6%, the control group, the total effective rate was 75.5%. The difference between the two groups was statistically significant (P <0.05). Conclusion: The use of drugs in the treatment of cardiovascular angina pectoris has definite curative effect and high safety. Simvastatin plus low molecular weight heparin sodium is more effective and worthy of promotion.